A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma

Diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL) are the two most aggressive forms of non‐Hodgkin lymphomas (NHLs). Spontaneous remission of DLBCL is a rare phenomenon. Immune system activation has been observed to play a significant role in the regression of untreated disease on s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Ashish K, Haq, Bushra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235008/
https://www.ncbi.nlm.nih.gov/pubmed/34194878
http://dx.doi.org/10.7759/cureus.15275
_version_ 1783714216003239936
author Sethi, Ashish K
Haq, Bushra
author_facet Sethi, Ashish K
Haq, Bushra
author_sort Sethi, Ashish K
collection PubMed
description Diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL) are the two most aggressive forms of non‐Hodgkin lymphomas (NHLs). Spontaneous remission of DLBCL is a rare phenomenon. Immune system activation has been observed to play a significant role in the regression of untreated disease on some occasions. We present a case of DLBCL in a 75-year-old male patient who has been free of disease for two months without any treatment due to possible immune-related mechanism, but later he presented with FL.
format Online
Article
Text
id pubmed-8235008
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-82350082021-06-29 A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma Sethi, Ashish K Haq, Bushra Cureus Internal Medicine Diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL) are the two most aggressive forms of non‐Hodgkin lymphomas (NHLs). Spontaneous remission of DLBCL is a rare phenomenon. Immune system activation has been observed to play a significant role in the regression of untreated disease on some occasions. We present a case of DLBCL in a 75-year-old male patient who has been free of disease for two months without any treatment due to possible immune-related mechanism, but later he presented with FL. Cureus 2021-05-27 /pmc/articles/PMC8235008/ /pubmed/34194878 http://dx.doi.org/10.7759/cureus.15275 Text en Copyright © 2021, Sethi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Sethi, Ashish K
Haq, Bushra
A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
title A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
title_full A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
title_fullStr A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
title_full_unstemmed A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
title_short A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
title_sort patient with regressed diffuse large b-cell lymphoma and aggressive follicular lymphoma
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235008/
https://www.ncbi.nlm.nih.gov/pubmed/34194878
http://dx.doi.org/10.7759/cureus.15275
work_keys_str_mv AT sethiashishk apatientwithregresseddiffuselargebcelllymphomaandaggressivefollicularlymphoma
AT haqbushra apatientwithregresseddiffuselargebcelllymphomaandaggressivefollicularlymphoma
AT sethiashishk patientwithregresseddiffuselargebcelllymphomaandaggressivefollicularlymphoma
AT haqbushra patientwithregresseddiffuselargebcelllymphomaandaggressivefollicularlymphoma

Ejemplares similares